BELLUS Health Inc (BLU) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 84 PAGES: 35

More Info
									              BELLUS Health Inc (BLU) - Financial and Strategic SWOT Analysis
                                          Review
        Reference Code: GDPH61499FSA                                                                                          Publication Date: APR 2012

          275 Armand-Frappier Blvd.                          Phone              +1 450 6804500                  Revenue          3.10 (million CAD)
          Laval, QC                                          Fax                +1 450 6804501                  Net Profit       3.42 (million CAD)
          H7V 4A7                                            Website            www.bellushealth.com            Employees        42
                                                                                BLU [Toronto         Stock                       Pharmaceuticals            &
          Canada                                             Exchange                                           Industry
                                                                                Exchange]                                        Healthcare

       Company Overview
       BELLUS Health Inc (BELLUS Health), formerly Neurochem Inc., is a global healthcare company, engaged in the developing and
       commercializing products to provide innovative health solutions for critical medical needs. BELLUS Health is mainly engages in
       pharmaceutical and nutraceutical activities. The product portfolio that the company offers under pharmaceutical division includes
       KIACTA, NRM8499 and under nutraceutical division includes VIVIMIND. The company targets disorders for which there are
       currently no known cures and limited therapies.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      BELLUS Health Inc, SWOT Analysis
         Dr. Francesco Bellini               Chairman                                 Strengths                              Weaknesses
         Roberto Bellini                     Chief Executive Officer
                                                                                      Focused Research and                   Termination of Drug
         Neil Flanzraich                     Director                                 Development Activities                 Developments
          Charles Cavell                     Chairman, Deputy
                                                                                      Orphan Drug Designation
         Franklin Berger                     Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Product Pipeline                       Industry Consolidation
         BELLUS Health Inc
                                                                                      Strategic Agreements                   Stringent Government
        Share Price (CAD) as on 05-Apr-                                  0.05                                                Regulations
        2012
        EPS (CAD)                                                       -0.01
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million CAD)                                            8        GlobalData

        Enterprise Value (million CAD)                                     41
        Shares Outstanding (million)                                     207
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Aug 10, 2011         BELLUS Health Reports Total Revenues Of
                                                                                                           $0.7m In Q2 2011
                                                                                      Jun 08, 2011         BELLUS Health Reports Net Income Of
                                                                                                           CAD3.3m For Q1 2011
                                                                                      Feb 23, 2011         BELLUS Health Reports              Net    Loss       Of
                                                                                                           CAD3.8m For Q4 2010
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData



       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




BELLUS Health Inc (BLU) - Financial and Strategic SWOT Analysis                                                                Reference Code: GDPH61499FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                       Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
         List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       BELLUS Health Inc - Key Facts ......................................................................................................................................................... 4
       BELLUS Health Inc - Key Employees ................................................................................................................................................ 5
       BELLUS Health Inc - Key Employee Biographies .............................................................................................................................. 6
       BELLUS Health Inc - Major Products and Services ............................................................................................................................ 7
       BELLUS Health Inc - Pharmaceutical Pipeline Products Data ........................................................................................................... 8
         BELLUS Health Inc, Pipeline Products by Therapy Area ................................................................................................................ 8
          BELLUS Health Inc, Pipeline Products by Development Phase ..................................................................................................... 9
       BELLUS Health Inc - History ............................................................................................................................................................ 11
       BELLUS Health Inc - Company Statement ....................................................................................................................................... 13
       BELLUS Health Inc - Locations And Subsidiaries ............................................................................................................................ 15
        Head Office ................................................................................................................................................................................... 15
          Other Locations & Subsidiaries ..................................................................................................................................................... 15
       Section 2 – Company Analysis ......................................................................................................................................................... 16
       BELLUS Health Inc - Business Description ...................................................................................................................................... 16
       BELLUS Health Inc - Corporate Strategy ......................................................................................................................................... 17
       BELLUS Health Inc - SWOT Analysis .............................................................................................................................................. 18
         SWOT Analysis - Overview........................................................................................................................................................... 18
          BELLUS Health Inc - Strengths .................................................................................................................................................... 18
             Strength - Focused Research and Development Activities ....................................................................................................... 18
             Strength - Orphan Drug Designation ......................................................................................................................................... 18
          BELLUS Health Inc - Weaknesses ............................................................................................................................................... 18
             Weakness - Termination of Drug Developments ....................................................................................................................... 18
          BELLUS Health Inc - Opportunities ......................................
								
To top